Skip to main content
OpenTrials

Clinical trial condition

Peritoneal Cancer

Explore clinical trials studying Peritoneal Cancer. Study availability and eligibility vary by location and protocol.

104 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Peritoneal Cancer trial results

Completed

A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer

NCT00461786

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT05445778

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Usa Mitchell Cancer Institute /ID# 269661 Mobile, Alabama, United States
  • Honorhealth Virginia G. Piper Cancer Care Network - Biltmore /ID# 269987 Phoenix, Arizona, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 269573 Irvine, California, United States
  • Moores Cancer Center at UC San Diego /ID# 269564 La Jolla, California, United States
View all 264 locations
View Trial Details
Active, Not Recruiting

A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.

NCT05335993

Conditions
Adenocarcinoma of Ovary, Adnexal Diseases, Carcinoma, +25 more
Locations
  • Duke Cancer Center Durham, North Carolina, United States
  • Stephenson Cancer Center- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
View Trial Details
Active, Not Recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

NCT04498117

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • John Muir Health Clinical Research Center Concord, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
View all 148 locations
View Trial Details
Active, Not Recruiting

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

NCT02873962

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

NCT02758951

Conditions
Abdominal Neoplasms, Body Temperature Changes, Colonic Diseases, +28 more
Locations
  • Ziekenhuis Oost-Limburg Genk, Flanders, Belgium
  • Amsterdam University Medical Centre, Location VUMC Amsterdam, Netherlands
  • Netherlands Cancer Institute Amsterdam, Netherlands
  • Catharina Hospital Eindhoven, Netherlands
View Trial Details
Active, Not Recruiting

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT06714617

Conditions
Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
Locations
  • SCRI-Denver HealthOne Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
  • Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
View Trial Details
Active, Not Recruiting

Nudge to Gynecologic Oncology

NCT06451263

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions